Edition:
United States

ViewRay Inc (VRAY.OQ)

VRAY.OQ on NASDAQ Stock Exchange Global Market

8.31USD
23 Feb 2018
Change (% chg)

$0.05 (+0.61%)
Prev Close
$8.26
Open
$8.28
Day's High
$8.37
Day's Low
$8.08
Volume
84,487
Avg. Vol
204,804
52-wk High
$10.63
52-wk Low
$4.40

Chart for

About

No overview information found for .
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 31.28 16.59
EPS (TTM): -- -- --
ROI: -- 9.69 35.07
ROE: -- 14.25 17.79

BRIEF-Viewray Announces Preliminary Q4 And Fiscal Year 2017 Results

* VIEWRAY ANNOUNCES PRELIMINARY FOURTH QUARTER AND FISCAL YEAR 2017 RESULTS

Jan 08 2018

BRIEF-Viewray Files For Resale By Selling Stockholders Of 6.7 Million Shares Of Co

* VIEWRAY INC FILES FOR RESALE BY SELLING STOCKHOLDERS OF 6.7 MILLION SHARES OF CO - SEC FILING Source text :[http://bit.ly/2Bp8yIs] Further company coverage:

Dec 22 2017

BRIEF-ViewRay Q3 loss per share $0.19

* Q3 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S

Nov 13 2017

BRIEF-‍Fosun International Ltd reports a 9.91 pct passive stake in Viewray Inc

* ‍Fosun International Ltd reports a 9.91 percent passive stake in Viewray Inc as of Oct 24, 2017 - SEC filing​​ Source text: (http://bit.ly/2xTl0hH) Further company coverage:

Nov 03 2017

BRIEF-Viewray's unit enters into amendment no. 3 to term loan agreement​

* On October 9, unit of co entered into amendment no. 3 to term loan agreement​ - SEC filing

Oct 13 2017

BRIEF-ViewRay launches clinical trial for pancreatic cancer using MRIdian System

* ViewRay launches clinical trial following compelling early pancreatic cancer data with MRidian System Source text for Eikon: Further company coverage:

Sep 25 2017

Earnings vs. Estimates

No consensus analysis data available.